REPLIGEN CORPORATION - COMMON STOCK
183.80
28-مارس-24 14:23:53
15 متأخرة بدقائق
الأسهم
-0.95
-0.51%
نطاق اليوم
182.56 - 187.25
ISIN
N/A
المصدر
NASDAQ
-
Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova
26 سبتمبر 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Appoints Jason K. Garland as Chief Financial Officer
12 سبتمبر 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Wells Fargo Healthcare Conference
01 سبتمبر 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
17 أغسطس 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
Repligen Reports Second Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance
02 أغسطس 2023 07:30:01 بحسب Nasdaq GlobeNewswire
-
Repligen to Report Second Quarter 2023 Financial Results
19 يوليو 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: REPLIGEN CORPORATION - COMMON STOCK
06 يوليو 2023 09:48:50 بحسب NetDania Notify
-
NetDania - New 12 months Low: REPLIGEN CORPORATION - COMMON STOCK
28 يونيو 2023 09:45:03 بحسب NetDania Notify
-
NetDania - New 12 months Low: REPLIGEN CORPORATION - COMMON STOCK
27 يونيو 2023 09:53:09 بحسب NetDania Notify
-
Repligen Corporation to Present at Upcoming Investor Conferences
31 مايو 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance
02 مايو 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen to Report First Quarter 2023 Financial Results
18 أبريل 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
14 مارس 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Reports Fourth Quarter and Full Year 2022 Financial Results
22 فبراير 2023 07:30:01 بحسب Nasdaq GlobeNewswire
-
Repligen Appoints Martin D. Madaus to Board of Directors
09 فبراير 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen to Report Fourth Quarter and Full Year 2022 Financial Results
08 فبراير 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Corporation to Present at 41st Annual J.P. Morgan Healthcare Conference
03 يناير 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Upcoming Investor Conferences
08 نوفمبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Repligen Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance
01 نوفمبر 2022 07:30:01 بحسب Nasdaq GlobeNewswire
-
Repligen Extends and Expands Long-Term Supply Agreement with Purolite for Affinity Ligands
01 نوفمبر 2022 07:00:01 بحسب Nasdaq GlobeNewswire